Profile data is unavailable for this security.
About the company
Organovo Holdings, Inc. is a biotechnology company that focuses on building high fidelity, three-dimensional (3D) tissues that recapitulate various aspects of human disease. The Company uses these models to identify gene targets responsible for driving the disease and intends to initiate drug discovery programs around these validated targets. It is initially focusing on the intestine and has ongoing 3D tissue development efforts in ulcerative colitis (UC) and Crohns disease (CD). The Company uses its technology to build functional 3D human tissues that mimic various aspects of native human tissue composition, architecture, function, and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Its 3D human tissue platform is multifaceted.
- Revenue in USD (TTM)242.00k
- Net income in USD-19.09m
- Incorporated2012
- Employees15.00
- LocationOrganovo Holdings IncSuite 110, 6275 Nancy Ridge DriveSAN DIEGO 92121United StatesUSA
- Phone+1 (858) 550-9994
- Fax+1 (302) 636-5454
- Websitehttps://organovo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemomab Therapeutics Ltd - ADR | 0.00 | -24.22m | 9.36m | 20.00 | -- | 0.0275 | -- | -- | -42.37 | -42.37 | 0.00 | 23.93 | 0.00 | -- | -- | 0.00 | -74.28 | -- | -90.33 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.39 | -- | -- | -- |
| Eterna Therapeutics Inc | 68.00k | -21.68m | 9.39m | 8.00 | -- | 4.21 | -- | 138.10 | -4.08 | -4.08 | 0.0128 | 0.4128 | 0.0019 | -- | 0.0988 | 8,500.00 | -60.69 | -169.05 | -75.78 | -223.00 | -173.53 | -- | -31,864.71 | -682.61 | -- | -33.19 | 0.7813 | -- | -- | -68.89 | 11.84 | -- | -58.86 | -- |
| Vaccinex Inc | 570.00k | -20.25m | 9.40m | 37.00 | -- | -- | -- | 16.49 | -63.98 | -63.98 | 1.23 | -2.59 | 0.0982 | -- | 1.00 | 15,405.41 | -348.91 | -262.29 | -1,283.74 | -- | -- | -- | -3,552.81 | -4,257.17 | -- | -59.75 | -- | -- | 107.27 | -4.67 | -2.20 | -- | -22.20 | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -10.01m | 9.43m | 9.00 | -- | -- | -- | -- | -2.04 | -2.04 | 0.00 | -0.0346 | 0.00 | -- | -- | 0.00 | -110.06 | -149.95 | -1,281.64 | -435.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 43.61 | -- | -- | -- |
| Cell MedX Corp | 70.00 | -96.91k | 9.51m | 0.00 | -- | -- | -- | 135,879.50 | -0.0029 | -0.0029 | 0.00 | -0.0024 | 0.0015 | -- | -- | -- | -202.28 | -792.55 | -- | -- | -685.71 | -- | -138,442.90 | -3,681.84 | -- | -3.17 | -- | -- | -54.53 | -- | 29.01 | -- | -- | -- |
| Moleculin Biotech Inc | 0.00 | -29.77m | 9.60m | 18.00 | -- | 0.3681 | -- | -- | -15.06 | -15.06 | 0.00 | 11.70 | 0.00 | -- | -- | 0.00 | -62.25 | -46.84 | -70.87 | -51.49 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.56 | -- | -21.54 | -- |
| Weed Inc | 0.00 | -31.55k | 9.63m | 2.00 | -- | 37.73 | 337.48 | -- | -0.0002 | -0.0002 | 0.00 | 0.0021 | 0.00 | -- | -- | 0.00 | -2.49 | -385.93 | -14.84 | -822.37 | -- | -- | -- | -- | -- | -16.98 | 0.3488 | -- | -- | -- | 97.93 | -- | -59.13 | -- |
| Kazia Therapeutics Ltd (ADR) | 14.70k | -13.34m | 9.75m | 12.00 | -- | 1.07 | -- | 663.33 | -0.8090 | -0.8090 | 0.0008 | 0.3444 | 0.0007 | -- | 73.97 | -- | -63.98 | -46.35 | -82.39 | -54.75 | -- | -- | -90,714.45 | -497.17 | -- | -- | 0.1297 | -- | 979.43 | -28.31 | 18.19 | -- | -- | -- |
| Medical Marijuana Inc | -100.00bn | -100.00bn | 9.77m | -- | -- | 0.1052 | -- | -- | -- | -- | -- | 0.019 | -- | -- | -- | -- | -- | -22.66 | -- | -23.11 | -- | 70.58 | -- | -145.52 | 1.79 | -- | 0.0479 | -- | 26.30 | 39.07 | 141.59 | -- | -0.016 | -- |
| BioCardia Inc | 477.00k | -11.57m | 9.89m | 16.00 | -- | -- | -- | 20.73 | -0.5525 | -0.5525 | 0.0225 | -0.0677 | 0.0747 | -- | 3.61 | 29,812.50 | -181.08 | -107.34 | -414.21 | -154.17 | -- | -- | -2,425.79 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| Organovo Holdings Inc | 242.00k | -19.09m | 9.92m | 15.00 | -- | 1.57 | -- | 40.99 | -2.17 | -2.17 | 0.0275 | 0.6283 | 0.0143 | -- | 4.44 | 12,100.00 | -112.40 | -51.24 | -123.59 | -54.90 | -- | -- | -7,886.36 | -1,269.78 | -- | -- | 0.00 | -- | -75.33 | -39.60 | -50.76 | -- | 5.99 | -- |
| 22nd Century Group Inc | 32.20m | -64.68m | 10.25m | 64.00 | -- | -- | -- | 0.3184 | -49.97 | -116.47 | 29.49 | -3.09 | 0.4531 | 5.70 | 8.81 | 503,187.50 | -76.94 | -46.78 | -105.06 | -54.18 | -27.00 | -2.11 | -169.81 | -107.95 | 0.4766 | -4.62 | 2.39 | -- | -20.49 | 4.03 | -76.94 | -- | 53.60 | -- |
| Guardion Health Sciences Inc | 12.25m | 158.03k | 10.47m | 9.00 | 65.59 | 1.28 | 58.98 | 0.8545 | 0.1243 | 0.1243 | 9.66 | 6.39 | 0.729 | 2.36 | 5.83 | 1,360,951.00 | 0.9405 | -77.90 | 1.12 | -86.55 | 44.04 | 42.45 | 1.29 | -176.93 | 6.98 | -- | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
| BioNexus Gene Lab Corp | 9.77m | -2.63m | 10.47m | 30.00 | -- | 1.08 | -- | 1.07 | -0.1389 | -0.1389 | 0.6873 | 0.5466 | 0.9703 | 7.98 | 5.33 | -- | -26.11 | -3.83 | -31.86 | -5.02 | 13.61 | 14.55 | -26.91 | -3.04 | 4.24 | -186.19 | 0.00 | -- | -10.60 | 115.07 | -638.56 | -- | 30.40 | -- |
Data as of Apr 25 2024. Currency figures normalised to Organovo Holdings Inc's reporting currency: US Dollar USD
7.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 353.61k | 3.52% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 147.52k | 1.47% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 101.49k | 1.01% |
| Geode Capital Management LLCas of 31 Dec 2023 | 74.16k | 0.74% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 38.78k | 0.39% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 27.83k | 0.28% |
| Raymond James & Associates, Inc. (Invt Mgmt)as of 31 Dec 2023 | 19.82k | 0.20% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 14.67k | 0.15% |
| Susquehanna Financial Group LLLPas of 31 Dec 2023 | 12.85k | 0.13% |
| G1 Execution Services LLCas of 31 Dec 2023 | 11.19k | 0.11% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
